Concepedia

Ori Yellin

OY

Statistics

Publications

20

Citations

1.1K

H-Index

17

Active since

2008

Affiliations

Oncotherapeutics (United States)(Current)

Institute for Myeloma & Bone Cancer Research

Cedars-Sinai Medical Center

Center for Cancer and Blood Disorders

Comprehensive Blood & Cancer Center

Ori Yellin is an author at Oncotherapeutics (United States) specializing in medicine, multiple myeloma, and multiple myeloma treatment.

ORCID

Publications per year

2008–2022

20

Publications

20

Serum <scp>B</scp>‐cell maturation antigen is elevated in multiple myeloma and correlates with disease status and survival

Eric Sanchez, Mingjie Li, Alex Kitto et al. · British Journal of Haematology · 2012 · 275 citations

, , +13

Monoclonal gammopathy of undetermined significance: a consensus statement

James R. Berenson, Kenneth C. Anderson, Robert A. Audell et al. · British Journal of Haematology · 2010 · 119 citations · Full text

, , +17

Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy

James R. Berenson, James Hilger, Ori Yellin et al. · Leukemia · 2014 · 76 citations · Full text

, , +17

Zoledronic Acid Markedly Improves Bone Mineral Density for Patients with Monoclonal Gammopathy of Undetermined Significance and Bone Loss

James R. Berenson, Ori Yellin, Ralph V. Boccia et al. · Clinical Cancer Research · 2008 · 70 citations

, , +16

Using a Powered Bone Marrow Biopsy System Results in Shorter Procedures, Causes Less Residual Pain to Adult Patients, and Yields Larger Specimens

James R. Berenson, Ori Yellin, Brent A. Blumenstein et al. · Diagnostic Pathology · 2011 · 57 citations · Full text

, , +16

1–5 of 20